Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Tuesday, February 19, 2019 · 476,812,432 Articles · 3+ Million Readers

China Genetic Testing Market 2018-2023: Analysis & Forecast by Prenatal, Carrier, New Born, Predictive/Presymptomatic & Diagnostic Testing

/EIN News/ -- Dublin, Jan. 10, 2019 (GLOBE NEWSWIRE) -- The "China Genetic Testing Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023" report has been added to's offering.

China Genetic Testing Market reached a value of US$ 1.43 Billion in 2017. Looking forward, the market is expected to reach a value of US$ 4.33 Billion by 2023, exhibiting a CAGR of 18.9% during 2018-2023.

Genetic testing, also known as DNA testing, provides the determination of bloodlines and the genetic diagnosis of vulnerabilities to diseases that can be inherited. It determines changes in chromosomes, genes, or proteins. The results obtained from a genetic test can confirm or rule out a suspected genetic disorder or help identify a person's chance of developing or passing on a genetic disorder. Genetic testing is becoming popular in China.

It may benefit many different interest groups, such as individuals and families with a history of genetic disorder, pregnant women, employers, and health or life insurance. This market is currently driven by a number of factors such as rising awareness regarding the benefits of genetic testing, availability of direct to consumer tests and increasing incidences of genetic disorders.

Over the past few years, there has been a significant rise in the awareness levels regarding the benefits of genetic testing in China. Genetic testing provides various technologies that help in the early detection of various chronic diseases and ensures its treatment and prevention. Moreover, a rise in the availability of Direct to consumer tests (DTC) which has increased the convenience and accessibility of such tests is also creating a positive impact in the growth of the market.

Moreover, In October, 2015, China announced that the iconic one-child policy had finally been replaced by a universal two-child policy. This is expected to increase the number of babies born each year and create a positive impact on the demand of the new born genetic testing segment.

Other major factors that are expected to drive this market include growing middle class, aging population, and expanding healthcare system.

Key Questions Answered in This Report:

  • How has the China genetic testing market performed so far and how will it perform in the coming years?
  • What is the breakup of the China genetic testing market based on the test type?
  • What is the breakup of the China genetic testing market based on the disease?
  • What is the breakup of the China genetic testing market based on the technology?
  • What is the breakup of the China genetic testing market based on the service provider?
  • What is the breakup of the China genetic testing market based on the testing sample?
  • What are the various stages in the value chain of the China genetic testing market?
  • What are the key provinces in the China genetic testing market?
  • What are the key driving factors and challenges in the China genetic testing market?
  • What is the structure of China genetic testing industry and who are the key players?
  • What is the degree of competition in the China genetic testing market?

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 China Genetic Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Test Type
5.4 Market Breakup by Disease
5.5 Market Breakup by Technology
5.6 Market Breakup by Service Provider
5.7 Market Breakup by Testing Sample
5.8 Market Forecast
5.9 SWOT Analysis
5.10 Value Chain Analysis
5.11 Porters Five Forces Analysis
5.12 Price Analysis
5.13 Key Success and Risk Factors

6 Market Breakup by Test Type
6.1 Prenatal Testing
6.2 Carrier Testing
6.3 New Born Testing
6.4 Predictive/Presymptomatic Testing
6.5 Diagnostic Testing

7 Market Breakup by Disease
7.1 Cancer
7.2 Down Syndrome
7.3 Thalassemia
7.4 Others

8 Market Breakup by Technology
8.1 Biochemical
8.2 Molecular
8.3 Cytogenetic

9 Market Breakup by Service Provider
9.1 Hospital Based Laboratories
9.2 Independent Laboratories
9.3 Specialty Clinics

10 Market Breakup by Testing Sample
10.1 Blood
10.2 Saliva
10.3 Hair
10.4 Others

11 Competitive Landscape
11.1 Market Structure
11.2 Key Players

12 Key Player Profiles
12.1 BGI
12.2 Shenzhen Huada Gene Technology Co Ltd.
12.3 Berry Genomics Co. ltd
12.4 Daan Gene Co. Ltd
12.5 WuXi NextCODE
12.6 Annoroad Gene Technology Co. Ltd.
12.7 WuXi PharmaTech

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

                             Laura Wood, Senior Press Manager
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: Genomics


Powered by EIN News

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release